tiprankstipranks
Trending News
More News >
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market

Compare Arvinas Holding Company (ARVN) vs. Competitors

Compare
1,040 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Arvinas Holding Company
$12.96
$859.96M
-16.14
-33.84%
4 Buy
0 Hold
0 Sell
Strong Buy
AnaptysBio
$47.90
$1.34B
-16.99
198.26%
9 Buy
1 Hold
0 Sell
Strong Buy
Meiragtx Holdings
$7.20
$626.22M
-3.41
5.26%
5 Buy
0 Hold
0 Sell
Strong Buy
Compass Therapeutics
$6.22
$1.13B
-13.59
84.02%
8 Buy
0 Hold
0 Sell
Strong Buy
Olema Pharmaceuticals
$25.01
$2.07B
-13.80
277.22%
11 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$15.10
$896.78M
-6.77
18.71%
9 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ARVN
Arvinas Holding Company
12.96
-5.74
-30.70%
ANAB
AnaptysBio
47.90
33.32
228.53%
MGTX
Meiragtx Holdings
7.20
0.39
5.73%
CMPX
Compass Therapeutics
6.22
2.72
77.71%
OLMA
Olema Pharmaceuticals
25.01
19.32
339.54%
BCAX
Bicara Therapeutics Inc.
15.10
2.97
24.48%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts